Setchell (83) demonstrated that soy isoflavones could stimulate the growth of ER-positive breast cancer cells through the ER singling pathway; while, some other studies stated the putative effect of isoflavones to inhibit carcinogenesis (84, 85). This evidence concerns the gene ESR1 and breast cancer.